Pharmacolog i Uppsala AB (publ) announced that Erik Hedlund, acting CEO, returns to the role of chairman of the board and Lars Gusch, previously COO, has been appointed CEO of the company. Pharmacolog's board has entered into a new agreement with current COO Lars Gusch, who will take over as CEO of the company with immediate effect. Lars Gusch was hired as COO at Pharmacolog in January 2022 and was previously development manager for the company in 2019-2020.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1005 SEK | -3.83% | +6.69% | +77.56% |
04-24 | Perpetua Medical AB Appoints Camilla Lonn as CFO | CI |
04-23 | Pharmacolog i Uppsala AB will Change its Ticker to PERP B from PHLOG B | CI |
1st Jan change | Capi. | |
---|---|---|
+77.56% | 1.02M | |
-24.07% | 17.02B | |
-42.47% | 2.84B | |
+13.40% | 1.8B | |
-10.21% | 1.5B | |
+32.69% | 1.33B | |
-21.01% | 911M | |
-25.79% | 849M | |
+5.15% | 824M | |
-27.85% | 604M |
- Stock Market
- Equities
- PERP B Stock
- News Pharmacolog i Uppsala AB
- Pharmacolog i Uppsala AB Announces CEO Changes